产碳青霉烯酶肺炎克雷伯菌感染82例药物治疗分析

    The drug analysis of 82 cases infected by Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae strains

    • 摘要: 目的:探讨我院产碳青霉烯酶(KPC)肺炎克雷伯菌感染患者的确切死亡率、常见危险因素与药物治疗之间的关系。方法:借助电子医疗记录,通过图表,回顾性分析82例产KPC细菌感染的患者(重复检出的患者只记录1次)的临床信息。结果:82例患者中,66例样本产KPC同时产超广谱内酰胺酶(ESBL),16例样本单产KPC,病死率分别为30例(45.5%)和5例(31.3%),差异无统计学意义(P0.05)。Cox回归分析:KPC菌株产ESBL使用硫酸多黏菌素B治疗有明显的影响(P0.01)。结论:使用硫酸多黏菌素B治疗产ESBL患者有一定的效果。

       

      Abstract: Objective: To explore the relationship between the exact mortality,common risk factors and medication data of the patients infected byKlebsiella pneumoniaecarbapenemase(KPC) production strains in this region.Methods:With the help of electric medical record and the chart,the clinical data of 82 cases infected by KPC-producing strains in department of microbiology in our hospital were analyzed retrospectively.Results:Among these 82 patients,66 cases were infected by KPC / ESBL co-producing isolates,16 cases were infected by KPC producing isolates only.The mortality was 30 cases(45.5%) and 5 cases(31.3%) respectively,and there was no statistical significance(P0.05).In Cox regression analysis,treatment with sulfuric acid polymyxin B had obvious effect(P0.01). Conclusions:The treatment with sulfuric acid polymyxin B had certain herapeutic effect on patients infected by KPC-producing strains.

       

    /

    返回文章
    返回